Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cognition Disorders

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, M; Igarashi, Y; Inokuchi, J; Iwasaki, K; Jimbo, M; Masuda, H; Mishima, K; Ohgami, Y; Yamagishi, K1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cognition Disorders

ArticleYear
A synthetic ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia.
    European journal of pharmacology, 2003, Feb-21, Volume: 462, Issue:1-3

    Topics: Animals; Apoptosis; Brain; Brain Ischemia; Cerebral Cortex; Cognition; Cognition Disorders; Gangliosides; Hippocampus; Male; Maze Learning; Morpholines; Neurons; Rats; Rats, Wistar; Spatial Behavior

2003